| Schedule Of Stock Repurchased Under Stock Repurchased Program |
| | | | | | | | | | | Shares Repurchased | Cost (in thousands) (1) | Average Price Paid per Share (2) | Repurchase activity for the fiscal quarter ended December 30, 2011 | 885,969 |
| $ | 26,068 |
| $ | 29.41 |
| Repurchase activity for the fiscal quarter ended March 30, 2012 | 1,575,891 |
| $ | 60,081 |
| $ | 38.11 |
| Total | 2,461,860 |
| $ | 86,149 |
| |
| | (1) | Cost of share repurchases includes the price paid per share and applicable commissions. |
| | (2) | Excludes commission costs. |
|
|
| Components Of Comprehensive Income |
| | | | | | | | | | | | | | | Fiscal Quarter Ended | Fiscal Year-to-Date Ended | | April 1,
2011 | March 30,
2012 | April 1,
2011 | March 30,
2012 | | (in thousands) | Net income including controlling interest | $ | 82,482 |
| $ | 88,317 |
| $ | 169,247 |
| $ | 161,683 |
| Other comprehensive income: | | | | | Foreign currency translation adjustment, net of tax | 2,237 |
| 1,934 |
| 3,344 |
| 1,557 |
| Unrealized losses on available-for-sale securities, net of tax | 220 |
| 306 |
| (656 | ) | 192 |
| Comprehensive income | 84,939 |
| 90,557 |
| 171,935 |
| 163,432 |
| Less: comprehensive income attributable to controlling interest | (555 | ) | (415 | ) | (933 | ) | (556 | ) | Comprehensive income attributable to Dolby Laboratories, Inc. | $ | 84,384 |
| $ | 90,142 |
| $ | 171,002 |
| $ | 162,876 |
|
|
|
| Schedule Of Accumulated Other Comprehensive Income |
| | | | | | | | September 30,
2011 | March 30,
2012 | | (in thousands) | Accumulated foreign currency translation gains, net of tax of ($2,653) at September 30, 2011 and ($3,026) at March 30, 2012 | $ | 6,834 |
| 8,239 |
| Accumulated unrealized gains on available-for-sale securities, net of tax of ($387) at September 30, 2011 and ($496) at March 30, 2012 | 699 |
| 891 |
| Total accumulated other comprehensive income | $ | 7,533 |
| 9,130 |
|
|
|
| Schedule Of Controlling Interest |
| | | | | | | | | | | | Dolby Laboratories, Inc. | Controlling Interest | Total | | (in thousands) | Balance at September 30, 2011 | $ | 1,663,513 |
| $ | 21,837 |
| $ | 1,685,350 |
| Net income | 161,279 |
| 404 |
| 161,683 |
| Distributions to controlling interest | — |
| (13 | ) | (13 | ) | Translation adjustments, net of taxes of ($373) | 1,405 |
| 152 |
| 1,557 |
| Unrealized losses on available-for-sale securities, net of taxes of ($109) | 192 |
| — |
| 192 |
| Stock-based compensation expense | 23,536 |
| — |
| 23,536 |
| Repurchase of common stock | (86,149 | ) | — |
| (86,149 | ) | Tax benefit from the exercise of stock options and vesting of restricted stock units | (2,513 | ) | — |
| (2,513 | ) | Common stock issued under employee stock plans, net of shares withheld for taxes | 3,524 |
| — |
| 3,524 |
| Balance at March 30, 2012 | $ | 1,764,787 |
| $ | 22,380 |
| $ | 1,787,167 |
|
|
| | | | | | | | | | | | Dolby Laboratories, Inc. | Controlling Interest | Total | | (in thousands) | Balance at September 24, 2010 | $ | 1,473,737 |
| $ | 20,942 |
| $ | 1,494,679 |
| Net income | 168,448 |
| 799 |
| 169,247 |
| Translation adjustments, net of taxes of ($301) | 3,210 |
| 134 |
| 3,344 |
| Unrealized losses on available-for-sale securities, net of taxes of $406 | (656 | ) | — |
| (656 | ) | Stock-based compensation expense | 22,111 |
| — |
| 22,111 |
| Repurchase of common stock | (75,124 | ) | — |
| (75,124 | ) | Tax benefit from the exercise of stock options and vesting of restricted stock units | 11,320 |
| — |
| 11,320 |
| Common stock issued under employee stock plans, net of shares withheld for taxes | 15,215 |
| — |
| 15,215 |
| Balance at April 1, 2011 | $ | 1,618,261 |
| $ | 21,875 |
| $ | 1,640,136 |
|
|